Clinical Trial Update: L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing adjunctive therapy with L-arginine and Vitamin D for smear-positive pulmonary tuberculosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• L-Arginine (L-Arginine)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Menzies School of Health Research | Conditions: Smear Positive Pulmonary Tuberculosis | Phase 3 | Status: COMPLETED